Lutris Pharma to Present at the 16th Annual European Life Sciences CEO Forum in March

TEL AVIV, Israel, Feb. 16, 2023 /PRNewswire/ — Lutris Pharma, a clinical stage biopharmaceutical company focused on improving anti-cancer therapies by reducing dose limiting side effects, today announced that Antoni Ribas, M.D., Ph.D., Chairman and Founder of Lutris Pharma, will present…

About the Author

has written 41718 stories on this site.

Copyright © 2010 Business and Corporate News.